These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39094631)

  • 1. Synergistic anticancer immunity in metastatic triple-negative breast cancer through an in situ amplifying Peptide-Drug Conjugate.
    Kim HR; Park SJ; Cho YS; Ko YG; Kim SY; Byun Y
    J Control Release; 2024 Sep; 375():681-697. PubMed ID: 39094631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-3 mediated switch therapy of self-triggered and long-acting prodrugs for metastatic TNBC.
    Kim HR; Cho YS; Chung SW; Choi JU; Ko YG; Park SJ; Kim SY; Byun Y
    J Control Release; 2022 Jun; 346():136-147. PubMed ID: 35447298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthetic MnSe nanobomb with low Mn content activates the cGAS-STING pathway and induces immunogenic cell death to enhance antitumour immunity.
    Gao W; Wang Y; Wang P; Kan W; Wang M; Li H; Wang X; Yuan P; Ma Y; Zhang J; Tian G; Zhang G
    Acta Biomater; 2024 Aug; 184():383-396. PubMed ID: 38936753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice.
    Ziaei E; Paiva IM; Yao SJ; Sarrami N; Mehinrad P; Lai J; Lavasanifar A; Kaur K
    Mol Pharm; 2023 Jul; 20(7):3570-3577. PubMed ID: 37307328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
    Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
    J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a Keratin 1 Targeting Peptide-Doxorubicin Conjugate in a Mouse Model of Triple-Negative Breast Cancer.
    Saghaeidehkordi A; Chen S; Yang S; Kaur K
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34063098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TROPION-Breast03: a randomized phase III global trial of datopotamab deruxtecan ± durvalumab in patients with triple-negative breast cancer and residual invasive disease at surgical resection after neoadjuvant therapy.
    Bardia A; Pusztai L; Albain K; Ciruelos EM; Im SA; Hershman D; Kalinsky K; Isaacs C; Loirat D; Testa L; Tokunaga E; Wu J; Dry H; Barlow W; Kozarski R; Maxwell M; Harbeck N; Sharma P
    Ther Adv Med Oncol; 2024; 16():17588359241248336. PubMed ID: 38686016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
    Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
    Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model.
    Dong H; Gao M; Lu L; Gui R; Fu Y
    Int J Nanomedicine; 2023; 18():3577-3593. PubMed ID: 37409026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.
    Luo C; Wang P; He S; Zhu J; Shi Y; Wang J
    Front Oncol; 2022; 12():919072. PubMed ID: 35795050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer.
    Wang Y; Chen Y; Ji DK; Huang Y; Huang W; Dong X; Yao D; Wang D
    J Nanobiotechnology; 2024 Aug; 22(1):461. PubMed ID: 39090622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
    Yao D; Wang Y; Bian K; Zhang B; Wang D
    Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.
    Yap ML; McFadyen JD; Wang X; Ziegler M; Chen YC; Willcox A; Nowell CJ; Scott AM; Sloan EK; Hogarth PM; Pietersz GA; Peter K
    Theranostics; 2019; 9(4):1154-1169. PubMed ID: 30867822
    [No Abstract]   [Full Text] [Related]  

  • 14. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity.
    Fu Y; Zhu X; Ren L; Wan J; Wang H
    ACS Nano; 2024 Jun; 18(23):14877-14892. PubMed ID: 38809421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
    Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
    Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research advances and new challenges in overcoming triple-negative breast cancer.
    Zong Y; Pegram M
    Cancer Drug Resist; 2021; 4(3):517-542. PubMed ID: 34888495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.
    Mediratta K; El-Sahli S; Marotel M; Awan MZ; Kirkby M; Salkini A; Kurdieh R; Abdisalam S; Shrestha A; Di Censo C; Sulaiman A; McGarry S; Lavoie JR; Liu Z; Lee SH; Li X; Sciumè G; D'Costa VM; Ardolino M; Wang L
    Front Immunol; 2024; 15():1366197. PubMed ID: 38601156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer.
    Jin F; Qi J; Liu D; You Y; Shu G; Du Y; Wang J; Xu X; Ying X; Ji J; Du Y
    J Control Release; 2021 Sep; 337():90-104. PubMed ID: 34274385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bio-nanoparticle based therapeutic vaccine induces immunogenic response against triple negative breast cancer.
    Bai X; Zhou Y; Lin Q; Huang CK; Zhang S; Carlson RI; Ghanbari H; Sun B; Wands JR; Dong X
    Am J Cancer Res; 2021; 11(9):4141-4174. PubMed ID: 34659881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.